ECG

Imperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine’s SmartHeart® Technology, to Be Presented at ACC 24

Retrieved on: 
Thursday, February 1, 2024
Cardiology, Biotechnology, Technology, Managed Care, Other Health, Health, Health Technology, Medical Devices, Internet, Telemedicine, Virtual Medicine, Clinical Trials, Telehealth, American College, Clinical trial, Patient, Imperial College London, SHL, ECG, Acute coronary syndrome, ACC, Pharmaceutical industry

The TELE-ACS trial is a pivotal study that marks a significant milestone in telemedicine and cardiovascular care.

Key Points: 
  • The TELE-ACS trial is a pivotal study that marks a significant milestone in telemedicine and cardiovascular care.
  • Erez Nachtomy, CEO of SHL Telemedicine, commented: “We would like to congratulate the team at Imperial College London on the acceptance of the TELE-ACS trial results for presentation at ACC 24.
  • This achievement is a testament to the researchers and their rigorous effort to conduct this groundbreaking work.
  • We very much look forward to seeing the presentation at ACC 24 which will share the embargoed full trial results with the global cardiology community.”
    ACC 24 Participants are invited to add the session to their itinerary using the following link: https://www.abstractsonline.com/pp8/#!/10973/presentation/22832

Smart Medical Devices Market Forecast: Substantial Growth to Reach US$271.3 Billion by 2028

Retrieved on: 
Tuesday, January 30, 2024
Unified Payments Interface, Growth, UID, JAM, GDP, Conditional sentence, IDF, Prevalence, Ecosystem, Vital signs, Economy, ECG, UN, Diabetes, Make, UPI, Hospital

The global smart medical devices market is estimated to grow at a CAGR of 10.33% reaching US$271.343 billion in 2028 from US$136.395 billion in 2021.

Key Points: 
  • The global smart medical devices market is estimated to grow at a CAGR of 10.33% reaching US$271.343 billion in 2028 from US$136.395 billion in 2021.
  • The global smart medical devices market growth is being propelled by the increasing demand for wireless and smartphone-compatible medical equipment, device technology breakthroughs, and increased consumer awareness of fitness.
  • The rise in the prevalence of chronic diseases including diabetes, cardiovascular, and respiratory problems has a big impact on the global smart medical devices market.
  • Indian government initiatives are also playing a significant role in the growth and development of the smart medical devices market in the country.

New Tool Reveals Gene Behavior in Bacteria

Retrieved on: 
Wednesday, January 24, 2024
Death, ECG, DNA replication, Alfred P. Sloan Foundation, TRIPS Agreement, Heart, DNA, Ralph, Champaign–Urbana metropolitan area, Publishing, Gene, University, Medicine, Genetics, Environment, Tick, In situ hybridization, Bacteria, NYU, Human, Cell cycle, Disease, NYU Langone Health, Protein, Nature, Doctor of Philosophy, Genome, National Institutes of Health, Messenger, Gene expression, Bangladesh Technical Education Board, Pathogenic bacteria, TRIP, Cell, Vaccine

This is due in part to the ability of bacteria to switch genes on and off as they sense environmental changes, including the presence of drugs.

Key Points: 
  • This is due in part to the ability of bacteria to switch genes on and off as they sense environmental changes, including the presence of drugs.
  • According to the study authors, organisms from bacteria to humans grow as their cells multiply by dividing, with each cell becoming two.
  • Specifically, the research team found that when DNA polymerase arrives at any specific gene, it disrupts the transcription in a way that reveals the state of that gene's regulatory status.
  • Ultimately, they believe that improvements in technology will enable them to dive ever deeper into gene behaviors in different bacterial species.

Wellysis Goes Global with ECG Monitor 'S-Patch', Enters US and Indian Markets

Retrieved on: 
Wednesday, January 24, 2024
Digital, ECG

Wellysis inked a significant supply agreement with a leading US provider of ECG services in November 2023, paving the way for S-Patch distribution across three important states: Texas, Arizona, and Louisiana, with the rollout starting in Texas.

Key Points: 
  • Wellysis inked a significant supply agreement with a leading US provider of ECG services in November 2023, paving the way for S-Patch distribution across three important states: Texas, Arizona, and Louisiana, with the rollout starting in Texas.
  • Additionally, Wellysis partnered with Dozee, a prominent bed monitoring solutions provider based in India, in October 2023.
  • "The US and India offer unparalleled opportunities for Wellysis," remarked Young Juhn, CEO of Wellysis.
  • Our focus is on showcasing S-Patch's versatility through diverse use cases, from remote patient monitoring to hospital bed integration."

PulseAI's Groundbreaking AI Algorithm Enhances Consumer ECG Diagnostics

Retrieved on: 
Thursday, January 11, 2024
Classification, ECG, Patient, Research, Burden, Cardiology, Alivecor, Health, Intelligence, Atrial fibrillation, Stroke, AI, Algorithm, Samsung, University Hospital of Basel, Apple, Physician, Medical device

BELFAST, Northern Ireland, Jan. 11, 2024 /PRNewswire/ -- PulseAI, a leader in artificial intelligence healthcare solutions, today announced a significant advancement in consumer device electrocardiogram (ECG) monitoring. Published in the Cardiovascular Digital Health Journal, the new study titled "Reducing the Burden of Inconclusive Smart-Device Single-lead ECG Tracings via a Novel Artificial Intelligence Algorithm" showcases the impactful role of PulseAI's neural network algorithm in cardiac monitoring.

Key Points: 
  • Published in the Cardiovascular Digital Health Journal, the new study titled " Reducing the Burden of Inconclusive Smart-Device Single-lead ECG Tracings via a Novel Artificial Intelligence Algorithm " showcases the impactful role of PulseAI's neural network algorithm in cardiac monitoring.
  • The results demonstrate that PulseAI's neural network algorithm significantly reduces inconclusive diagnoses from commercially available consumer ECG devices by Apple, Samsung, AliveCor and Fitbit.
  • The research highlights the challenge of high rates of inconclusive readings from consumer ECG devices.
  • PulseAI's algorithm offers a reliable, cross-platform solution that integrates seamlessly with various consumer and clinical ECG devices.

PulseAI's Groundbreaking AI Algorithm Enhances Consumer ECG Diagnostics

Retrieved on: 
Thursday, January 11, 2024
Classification, ECG, Patient, Research, Burden, Cardiology, Alivecor, Health, Intelligence, Atrial fibrillation, Stroke, AI, Algorithm, Samsung, University Hospital of Basel, Apple, Physician, Medical device

BELFAST, Northern Ireland , Jan. 11, 2024 /PRNewswire/ -- PulseAI, a leader in artificial intelligence healthcare solutions, today announced a significant advancement in consumer device electrocardiogram (ECG) monitoring. Published in the Cardiovascular Digital Health Journal, the new study titled "Reducing the Burden of Inconclusive Smart-Device Single-lead ECG Tracings via a Novel Artificial Intelligence Algorithm" showcases the impactful role of PulseAI's neural network algorithm in cardiac monitoring.

Key Points: 
  • Published in the Cardiovascular Digital Health Journal, the new study titled " Reducing the Burden of Inconclusive Smart-Device Single-lead ECG Tracings via a Novel Artificial Intelligence Algorithm " showcases the impactful role of PulseAI's neural network algorithm in cardiac monitoring.
  • The results demonstrate that PulseAI's neural network algorithm significantly reduces inconclusive diagnoses from commercially available consumer ECG devices by Apple, Samsung, AliveCor and Fitbit.
  • The research highlights the challenge of high rates of inconclusive readings from consumer ECG devices.
  • PulseAI's algorithm offers a reliable, cross-platform solution that integrates seamlessly with various consumer and clinical ECG devices.

Goertek Unveils Cutting-Edge Technologies at CES 2024

Retrieved on: 
Wednesday, January 10, 2024
Keeper, ECG, Heart rate, Acoustics, TWS, Temperature, Multimedia, Electronics, RNC, COC, Pressure, Qualcomm, CES, MicroLED, ANC, Liquid crystal on silicon, OLGA, Antirrhinum, FOV, Time of flight, Blood pressure

LAS VEGAS, Jan. 10, 2024 /PRNewswire/ -- Goertek Inc. made its presence felt once again at CES when the annual event opened its doors in Las Vegas on January 9. The technology innovator returned to the event with a line-up of novel technologies and solutions in the realms of acoustics, optics and electronics, aimed at driving advancement across the consumer electronics sector.

Key Points: 
  • LAS VEGAS, Jan. 10, 2024 /PRNewswire/ -- Goertek Inc. made its presence felt once again at CES when the annual event opened its doors in Las Vegas on January 9.
  • Goertek exhibited an array of speaker units and modules for cell phones, wearables, headphones and smart speakers.
  • Goertek also highlighted its advanced cockpit-based active Road-Noise Cancellation (RNC) solutions, demonstrating its commitment to enhancing the automotive electronics landscape.
  • Goertek remains steadfast in its commitment to innovation, with a focused aim to continually enhance its core competitiveness.

Vivalink's Global Impact Spans Over 50 Countries: Enabling Digital Healthcare Solutions Worldwide

Retrieved on: 
Wednesday, January 10, 2024
RPM, ECG, Stanford University, UCSF, Harvard Medical School, Amazon Web Services, Intelligence, University of Oxford, UCLA, Harvard University, Omron, Machine learning, GE HealthCare, Medical device

CAMPBELL, Calif., Jan. 10, 2024 /PRNewswire/ -- Vivalink, a leading provider of digital healthcare solutions, proudly announces significant milestones achieved in 2023, reinforcing its commitment to advancing the adoption of remote patient monitoring in healthcare and clinical trials. The company's innovative Biometrics Data Platform, powered by Amazon Web Services, enables digital healthcare innovations with unparalleled data insights, contributing to breakthroughs in artificial intelligence and machine learning applications for healthcare.

Key Points: 
  • Vivalink's digital healthcare network expands globally with more than 300 partnerships worldwide, reaffirming its role as the preferred choice for remote patient monitoring.
  • Key achievements for Vivalink in 2023 include:
    3X year-over-year sales growth, a testament to the increasing demand for Vivalink's remote patient monitoring solutions.
  • Investment from a group of investors including Niterra to drive continued innovation in digital healthcare and remote patient monitoring.
  • As the adoption of RPM solutions continues to grow worldwide, the technology's real promise is to provide healthcare for all.

Withings Announces BeamO The Revolutionary At-home Health Checkup

Retrieved on: 
Tuesday, January 9, 2024
LVCC, ECG, Hand, Heart rate, Overalls, Heart, Health, Electrode, Home, Thermoregulation, Atrial fibrillation, LED, History, Arrhythmia, PPG, Skin, Ventricular fibrillation, Movement, Fever, Oxygen saturation (medicine), Future, FDA, Physician, Wi-Fi, CES, Infection, Piezoelectricity, Smartphone, Medical device

With these capabilities, BeamO will conduct a 4-in-1 health checkup of body temperature, heart, and lung health in under a minute.

Key Points: 
  • With these capabilities, BeamO will conduct a 4-in-1 health checkup of body temperature, heart, and lung health in under a minute.
  • By automatically syncing with the Withings app through Wi-Fi, BeamO creates comprehensive health records over time.
  • To better track individual and family health journeys, Withings also introduces new capabilities within the Withings App for BeamO and its entire family of connected health products.
  • A CES Innovations Award Honoree, BeamO will be demoed during CES at the Withings Booth (LVCC NH #8637) .

Revolutionizing Relaxation: OSIM Combines AI and Wellness Tech in Well-Being, Gaming and Massage Chairs at CES 2024

Retrieved on: 
Tuesday, January 9, 2024
Well, Massage, Artificial intelligence, ECG, Peter Hancock (professor), Health, Music, Heart rate, Overalls, OSIM, Temperature, Neck, Respiratory rate, Relaxation, AI, PPG, Consumer Electronics Show, CES, System, Machine learning

NEW YORK, Jan. 9, 2024 /PRNewswire-PRWeb/ -- OSIM, a global leader in wellness tech and healthy lifestyle products, is unveiling three new chairs at the annual Consumer Electronics Show (CES) in Las Vegas on Jan. 9-12, 2024. Aligning with OSIM's mission to create connected wellness tech solutions, the new thoughtfully designed products - uLove 3 Well-Being Chair, uThrone V Gaming Massage Chair and DIY Massage Chair - seamlessly integrate wellness into customers' everyday lives. Through its user-centric and intelligent wellness ecosystem of synergistic products, solutions, and the OSIM Well-Being App, OSIM empowers customers to measure, monitor and manage their stress to improve their overall health.

Key Points: 
  • Aligning with OSIM's mission to create connected wellness tech solutions, the new thoughtfully designed products - uLove 3 Well-Being Chair, uThrone V Gaming Massage Chair and DIY Massage Chair - seamlessly integrate wellness into customers' everyday lives.
  • Through its user-centric and intelligent wellness ecosystem of synergistic products, solutions, and the OSIM Well-Being App, OSIM empowers customers to measure, monitor and manage their stress to improve their overall health.
  • For a personalized wellness experience with the uLove 3, the OSIM Well-Being App generates an AI Stress Analysis that measures Body Tension Scores using biosensors with electrocardiogram (ECG) technology.
  • Once stress levels are identified, the DIY Massage Chair creates recommended Body Tension Programs that reduce stress levels and improve overall wellness.